|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gastric autoimmune disorders in patients with chronic hepatitis C before,during and after interferon-alpha therapy显示文摘AIM: To explore the prevalence of autoimmune gastritis in chronic hepatitis C virus (HCV) patients and the influence of α-intefferon (IFN) treatment on autoimmune gastritis.METHODS: We performed a prospective study on 189patients with positive anti-HCV and viral RNA enrolled in a 12-month IFN protocol. We evaluated: a) the baseline prevalence of autoimmune gastritis, b) the impact of IFN treatment on development of biochemical signs of autoimmune gastritis (at 3, 6 and 12 months), c) the evolution after IFN withdrawal (12 months) in terms of anti-gastric-parietal-cell antibodies (APCA), gastrin, anti-thyroid, and anti-non-organ-specific antibodies.RESULTS: APCA positivity and 3-fold gastrin levels were detected in 3 (1.6 %) and 9 (5 %) patients, respectively, at baseline, in 25 (13 %) and 31 (16 %) patients at the end of treatment (both P<0.001, vs baseline), and in 7 (4 %) and 14 (7 %) patients 12 months after withdrawal (P=0.002and ,P=0.01 respectively, vs baseline; P=not significant vs end of treatment). The development of autoimmune gastritis was strictly associated with the presence of autoimmune thyroiditis (P =0.0001), no relationship was found with other markers of autoimmunity.CONCLUSION: In HCV patients, IFN frequently precipitates latent autoimmune gastritis, particularly in females. Following our 12-month protocol, the phenomenon generally regressed. Since APCA positivity and high gastrin levels are associated with the presence of antithyroid antibodies,development of autoimmune thyroiditis during IFN treatment may provide a surrogate preliminary indicator of possible autoimmune gastritis to limit the need for invasive examinations. | Carlo Fabbri M.Francesca Jaboli Silvia Giovanelli Francesco Azzaroli Alessandro Pezzoli Esterita Accogli Stefania Liva Giovanni Nigro Anna Miracolo Davide Festi Antonio Colecchia Marco Montagnani Enrico Roda Giuseppe Mazzella | 2003 | World Journal of Gastroenterology2003，9，7： | 3 |
| 2 | Hepatocellular Carcinomas and Primary Liver Tumors as Predictive Factors for Postoperative Mortality after Liver Resection: A Meta-Analysis of More than 35,000 Hepatic Resections显示文摘 | Ramacciato Giovanni D’Angelo Francesco Baldini Rossella Petrucciani Niccoló Antolino Laura Aurello Paolo Nigri Giuseppe Bellagamba Riccardo Pezzoli Francesca Balesh Albert Cucchetti Alessandro Cescon Matteo Del Gaudio Massimo Ravaioli Matteo | 2012 | EN2012，，4： | 2 |
| 3 | Asymmetry and freezing of gait in parkinsonian patients显示文摘 | Frazzitta G Pezzoli G Bertotti G | 2013 | J Neurol2013，260，： | 1 |
| 4 | Packed with Salmonella--in- vestigation of an international outbreak of Salmonella Senftenberg infection linked to contamination of prepacked basil in 2007显示文摘 | Pezzoli L Elson R Little CL | 2008 | Foodbome Pathogens and Disease2008，5，5： | 1 |
| 5 | Pergolide mesylate in Parkinson 'sdisease treatment显示文摘 | Canesi M Pesenti A | 1995 | J Neural Transm Suppl1995，45，： | 1 |
| 6 | Shaking table tests on 24 simple masonry buildings 显示文摘 | Benedetti D Carydis P Pezzoli P | 1998 | Earthquake Engineering and Structural Dynamics1998，27，： | 1 |
| 7 | Levodopa in Parkinson's disease: from the past to the future 显示文摘 | Pezzoli G Zini M | 2010 | Expert Opin Pharmacother2010，11，4： | 1 |
| 8 | A crossover, controlled stud ycomparing pergolide with bromocriptine as an adjunct to levodopa for the treat mentof Parkinson's disease显示文摘 | Martignoni E Pacchett C | 1995 | Neurology1995，45，3： | 1 |
| 9 | Bioreducible liposomes for gene delivery: from the formulation to the mechanism of action 显示文摘 | Candiani G Pezzoli D Ciani L | 2010 | PLoS One2010，5，13： | 1 |
| 10 | Novel membrane-bound GM-CSF vaccines for the treatment of cancer :generation and evaluation of mbGM-CSF mouse B16F10melanoma cell vaccine 显示文摘 | YEI S BARTHOLOMEW R M PEZZOLI P | 2002 | Gene Ther2002，9，19： | 1 |
| 11 | Sustainable Development: A Transdisciplinary Overview of the Literature 显示文摘 | Pezzoli K | 1997 | Journal of Environmental Planning and Management1997，40，5： | 1 |
| 12 | Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults:a randomized trial显示文摘 | Nass R Pezzoli SS Oliveri MC | 2008 | Ann Int Med2008，149，9： | 1 |
| 13 | Levodopa in parkinson~ disease:from the past to the future 显示文摘 | PEZZOLI C ZINI M | 2010 | Expert Opin Pharmacother2010，11，4： | 1 |
| 14 | Exposure to pesticides or solvents and risk of Parkinson disease显示文摘 | Pezzoli G Cereda E | 2013 | Neurology2013，80，22： | 1 |
| 15 | Asymmetry and freezing of gait in parkinsonian patients显示文摘 | Frazzitta G Pezzoli G Bertotti G | 2013 | J Neurol2013，260，： | 1 |
| 16 | Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial 显示文摘 | Nass R Pezzoli SS Oliveri MC | 2008 | Ann Intern Med2008，149，： | 1 |
| 17 | QuantiFERON- TB Gold test in the identification of latent tuberculosis infection in immigrants显示文摘 | CARVALHO A C PEZZOLI M C EL-HAMAD I | 2007 | J Infect2007，55，2： | 1 |
| 18 | Gene expression analysis of troglitazone reveals its impact on multiple pathways in cell culture:a case for in vitro platforms combined with gene expression analysis for early (idiosyncratic) toxicity screening 显示文摘 | Vansant G Pezzoli P Saiz R | 2006 | Int J Toxicol2006，25，2： | 1 |
| 19 | Controlled-protein dietary regimens for Parkinson's disease显示文摘 | Cereda E Barichella M Pezzoli G | 2010 | Nutritional Neuroscience2010，13，1： | 1 |
| 20 | The status of dopamine nerve terminals in Parkinson’s disease and essential tremor: a PET study with the tracer [11-C]FE-CIT显示文摘 | A. Antonini R. M. Moresco C. Gobbo R. De Notaris A. Panzacchi P. Barone S. Calzetti A Negrotti G. Pezzoli F. Fazio | 2001 | Neurological Sciences2001，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员